Patents by Inventor Takatomo Yoneoka

Takatomo Yoneoka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL AGENT FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS OR SUPPRESSING DISEASE PROGRESS THEREOF
    Publication number: 20220047551
    Abstract: The invention provides a method for treating ALS or suppressing the disease progress thereof, or treating symptoms caused by ALS or suppressing the disease progress thereof by administering an agent containing, as an active ingredient, 3-methyl-1-phenyl-2-pyrazolin-5-one or a physiologically acceptable salt thereof, to a patient that complies with specific criteria. The agent is administered by repeating a 14-day administration period and a 14-day drug holiday period, or by establishing an initial 14-day administration period and an initial 14-day drug holiday period and then repeating an administration period for 10 out of 14 days and a 14-day drug holiday period.
    Type: Application
    Filed: October 28, 2021
    Publication date: February 17, 2022
    Applicant: Mitsubishi Tanabe Pharma Corporation
    Inventor: Takatomo YONEOKA
  • PHARMACEUTICAL AGENT FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS OR SUPPRESSING DISEASE PROGRESS THEREOF
    Publication number: 20140228420
    Abstract: The invention provides a method for treating ALS or suppressing the disease progress thereof, or treating symptoms caused by ALS or suppressing the disease progress thereof by administering an agent containing, as an active ingredient, 3-methyl-1-phenyl-2-pyrazolin-5-one or a physiologically acceptable salt thereof, to a patient that complies with specific criteria.
    Type: Application
    Filed: September 5, 2012
    Publication date: August 14, 2014
    Applicant: MITSUBISHI TANABE PHARMA CORPORATION
    Inventor: Takatomo Yoneoka
  • Novel Therapeutic Agent For Amyotrophic Lateral Sclerosis (Als) or Diseases Caused by Als
    Publication number: 20080161378
    Abstract: There is provided a medicament for treating amyotrophic lateral sclerosis (ALS) or symptoms caused by ALS and/or suppressing the progression thereof, which is characterized in the usage, dosage and administration period of the pyrazolone derivative represented by the following formula (wherein each symbol indicates the same meaning as that defined in the specification):
    Type: Application
    Filed: February 9, 2005
    Publication date: July 3, 2008
    Inventors: Hiide Yoshino, Takatomo Yoneoka